The effect of topical chamomile herbal product on the symptoms of patients with muscle cramps

Phase 3

Recruiting

Conditions: muscle cramp.
Cramp and spasm
R25.2

Registration Number: IRCT20200105046009N7

Lead Sponsor: Babol University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 64

Inclusion Criteria

Men and women aged 20 to 60 years
Presence of muscle cramp in the gastrocnemius muscle
The presence of pain with a vas score greater than six

Exclusion Criteria

Lack of complete evaluation to monitor the treatment process
Lack of satisfaction during treatment
The presence of underlying diseases related to cramps
Using other painkillers
Performing procedures that lead to the improvement of muscle cramps
History of recurrent cramps without clear cause

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain index. Timepoint: The VAS measurement is measured before the intervention and on even days after the start of the intervention, and the treatment continues until the pain index reaches 4 or a change of 1.7 based on the MCID. Method of measurement: Pain intensity measurement using VAS tool.;Duration of treatment. Timepoint: VAS is measured before the intervention and on even days after the start of the intervention, and the examination of the pain index continues until the day it reaches the number 4 or the change rate of 1.7 based on the MCID. Method of measurement: Pain intensity measurement using VAS tool.

Secondary Outcome Measures

Name	Time	Method
Redness. Timepoint: Measurements are taken before the intervention and on even days after the start of the intervention, and the treatment continues until the pain index reaches 4 or a change of 1.7 based on the MCID. Method of measurement: By patient report or evaluator observation.;Itching. Timepoint: Measurements are taken before the intervention and on even days after the start of the intervention, and the treatment continues until the pain index reaches 4 or a change of 1.7 based on the MCID. Method of measurement: By patient report or evaluator observation.;Swelling. Timepoint: Measurements are taken before the intervention and on even days after the start of the intervention, and the treatment continues until the pain index reaches 4 or a change of 1.7 based on the MCID. Method of measurement: By patient report or evaluator observation.